Live Breaking News & Updates on Roryb Riggs|Page 8

Stay updated with breaking news from Roryb riggs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioSig Technologies (NASDAQ:BSGM) Given "Speculative Buy" Rating at Taglich Brothers

Royalty Pharma (NASDAQ:RPRX – Get Rating) had its price objective raised by Morgan Stanley from $48.00 to $50.00 in a report published on Monday, The Fly reports. Morgan Stanley currently has an overweight rating on the biopharmaceutical company’s stock. Other equities analysts have also recently issued reports about the stock. Tigress Financial raised their price […] ....

United States , Roryb Riggs , Marshall Urist , Voya Investment Management , Morgan Stanley , Victory Capital Management Inc , National Bank , Macquarie Group Ltd , Royalty Pharma , Get Rating , Director Rory , Ivy Capital Management , Capital Management , Investment Management , Macquarie Group , Royalty Pharma Daily , Nasdaq Rprx , Boost Price Target ,

Royalty Pharma (NASDAQ:RPRX) PT Raised to $50.00

Royalty Pharma (NASDAQ:RPRX – Get Rating) had its target price lifted by investment analysts at Morgan Stanley from $48.00 to $50.00 in a note issued to investors on Monday, The Fly reports. The brokerage presently has an “overweight” rating on the biopharmaceutical company’s stock. Morgan Stanley’s price objective suggests a potential upside of 36.87% from […] ....

United States , Marshall Urist , Roryb Riggs , Morgan Stanley , Voya Investment Management , Victory Capital Management Inc , Securities Exchange Commission , Macquarie Group Ltd , United Capital Financial Advisers , Royalty Pharma , Get Rating , Director Rory , Exchange Commission , Ivy Capital Management , Capital Management , Investment Management , Capital Financial Advisers , Royalty Pharma Daily , Nasdaq Rprx , Boost Price Target ,

Graypoint LLC Sells 40,026 Shares of Royalty Pharma plc (NASDAQ:RPRX)

Graypoint LLC lessened its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Get Rating) by 47.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 43,975 shares of the biopharmaceutical company’s stock after selling 40,026 shares during the period. Graypoint LLC’s holdings in Royalty Pharma were […] ....

New York , United States , Roryb Riggs , Marshall Urist , China Universal Asset Management Co , Royalty Pharma Company Profile , Morgan Stanley , York State Common Retirement Fund , Securities Exchange Commission , Royalty Pharma , Get Rating , Universal Asset Management , Global Investments , Strs Ohio , Tigress Financial , Pharma Trading Down , Exchange Commission , Director Rory , Royalty Pharma Daily , Nasdaq Rprx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Versor Investments LP

Versor Investments LP boosted its position in Royalty Pharma plc (NASDAQ:RPRX – Get Rating) by 69.9% during the fourth quarter, Holdings Channel.com reports. The fund owned 32,790 shares of the biopharmaceutical company’s stock after purchasing an additional 13,490 shares during the quarter. Versor Investments LP’s holdings in Royalty Pharma were worth $1,296,000 at the end […] ....

United States , Marshall Urist , Roryb Riggs , Blackrock Inc , Manufacturers Life Insurance Company , Morgan Stanley , Northern Trust Corp , Holdings Channel , Vanguard Group Inc , Versor Investments , Royalty Pharma , Get Rating , Street Corp , Trust Corp , Tigress Financial , Director Rory , Visit Holdingschannel , Royalty Pharma Daily , Nasdaq Rprx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,